NanoGroup S.A.
NNG | WAR
Overview
Corporate Details
- ISIN(s):
- PLNNGRP00011 (+3 more)
- LEI:
- 259400HXWEAZUWRLY648
- Country:
- Poland
- Address:
- Warszawa Rakowiecka 36, 02-532 Warszawa
- Website:
- https://en.nanogroup.eu/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Mission of NanoGroup is to build a cluster of medical and biotechnological companies active in the field of diagnostics, therapy and rehabilitation of oncological patients. Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups. NanoGroup plans to sell licenses to its early-stage solutions (pre-clinical and clinical phase 1st) to international biotech companies and pharmaceutical companies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-11 16:14 |
Regulatory News Service
Oświadczenie KDPW
|
Polish | 175.4 KB | |
| 2025-08-11 16:14 |
Regulatory News Service
Asymilacja akcji oznaczonych kodem "PLNNGRP00086" z notowanymi akcjami oznaczon…
|
Polish | 669 bytes | |
| 2025-08-06 18:01 |
Regulatory News Service
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii L1, M1, M2, M3, M4…
|
Polish | 2.0 KB | |
| 2025-08-04 14:39 |
Regulatory News Service
Zawarcie przez spółkę zależną od NanoGroup S.A. umowy o dofinansowanie projektu…
|
Polish | 6.2 KB | |
| 2025-07-22 18:59 |
Transaction in Own Shares
Zawarcie transakcji sprzedaży akcji własnych spółki - Content (PL)
|
Polish | 1.2 KB | |
| 2025-07-10 13:26 |
Share Issue/Capital Change
Uchwała
|
Polish | 67.2 KB | |
| 2025-07-10 13:26 |
Capital/Financing Update
Podjęcie przez Zarząd uchwały w sprawie emisji akcji serii K w ramach podwyższe…
|
Polish | 4.6 KB | |
| 2025-07-02 20:24 |
Regulatory News Service
Dokument dopuszczenia akcji
|
Polish | 738.8 KB | |
| 2025-07-02 20:24 |
Registration Form
Korekta nr 2 dokumentu związanego z dopuszczeniem do obrotu na rynku regulowany…
|
Polish | 6.8 KB | |
| 2025-07-02 15:52 |
Regulatory News Service
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-07-02 15:52 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 460 bytes | |
| 2025-07-02 13:12 |
Regulatory News Service
Powiadomienie
|
Polish | 5.3 KB | |
| 2025-07-02 13:12 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 458 bytes | |
| 2025-06-27 13:24 |
Declaration of Voting Results & Voting Rights Announcements
Lista Akcjonariuszy
|
Polish | 49.9 KB | |
| 2025-06-27 13:24 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
|
Polish | 372 bytes |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |